Maternus-Kliniken Aktiengesellschaft

LSE:0N2K Stock Report

Market Cap: €36.7m

Maternus-Kliniken Past Earnings Performance

Past criteria checks 0/6

Maternus-Kliniken's earnings have been declining at an average annual rate of -12.3%, while the Healthcare industry saw earnings growing at 31.3% annually. Revenues have been declining at an average rate of 3.9% per year.

Key information

-12.3%

Earnings growth rate

-12.5%

EPS growth rate

Healthcare Industry Growth12.6%
Revenue growth rate-3.9%
Return on equityn/a
Net Margin-6.3%
Last Earnings Update30 Jun 2024

Recent past performance updates

No updates

Recent updates

No updates

Revenue & Expenses Breakdown

How Maternus-Kliniken makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

LSE:0N2K Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 24109-700
31 Mar 24106-1100
31 Dec 23102-1400
30 Sep 23102-1700
30 Jun 23102-1900
31 Mar 23105-1600
31 Dec 22107-1400
30 Sep 22108-1000
30 Jun 22110-600
31 Mar 22111-400
31 Dec 21111-300
30 Sep 21114-500
30 Jun 21116-700
31 Mar 21115-800
31 Dec 20114-1000
30 Sep 20116-1010
30 Jun 20117-1020
31 Mar 20121-1030
31 Dec 19124-1050
30 Sep 19125-760
30 Jun 19125-580
31 Mar 19125-3110
31 Dec 18124-2130
30 Sep 18125-2170
30 Jun 18126-2210
31 Mar 18126-2170
31 Dec 17127-1140
30 Sep 171270140
30 Jun 171262140
31 Mar 171251140
31 Dec 161241140
30 Sep 161244210
30 Jun 161242140
31 Mar 161242140
31 Dec 151232140
30 Sep 1512328140
30 Jun 1512428140
31 Mar 1512328140
31 Dec 1412227140
30 Sep 14120-9150
30 Jun 14118-10150
31 Mar 14115-11150

Quality Earnings: 0N2K is currently unprofitable.

Growing Profit Margin: 0N2K is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 0N2K is unprofitable, and losses have increased over the past 5 years at a rate of 12.3% per year.

Accelerating Growth: Unable to compare 0N2K's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 0N2K is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (14.9%).


Return on Equity

High ROE: 0N2K's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/30 02:53
End of Day Share Price 2025/01/27 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Maternus-Kliniken Aktiengesellschaft is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sven KuertenDz Bank Ag
Hartmut SchmidtHPS Research